---
title: "Heron Therapeutics to report Q2 results, host conference call and webcast"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293932913.md"
description: "Heron Therapeutics will report its Q2 results and host a conference call and live webcast on August 10, 2026, at 8:30 a.m. ET."
datetime: "2026-07-27T12:31:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293932913.md)
  - [en](https://longbridge.com/en/news/293932913.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293932913.md)
---

# Heron Therapeutics to report Q2 results, host conference call and webcast

-   Heron Therapeutics schedules a conference call, live webcast on Aug. 10, 2026 at 8:30 a.m. ET to report Q2 results. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heron Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607270830PRIMZONEFULLFEED9767924) on July 27, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [HRTX.US](https://longbridge.com/en/quote/HRTX.US.md)

## Related News & Research

- [HRTX: Q2 2026 net revenue grew 9% sequentially, but full-year guidance was withdrawn amid legal uncertainty](https://longbridge.com/en/news/295405345.md)
- [Heron Therapeutics Q2 revenue rises on acute care growth, withdraws 2026 outlook](https://longbridge.com/en/news/295404922.md)
- [BIO-key to host Q2 investor call and webcast](https://longbridge.com/en/news/295230722.md)
- [Perma-Fix reschedules Q2 2026 business update conference call](https://longbridge.com/en/news/295525637.md)
- [Scana ASA to publish Q2 2026 results, host webcast presentation](https://longbridge.com/en/news/295626303.md)